India’s space agency on Sunday (February 2) reported the partial failure of its NVS-02 navigation satellite due to the non-firing of its engines in space. This was the latest in a series of setbacks ...

NVS-02 satellite mission update: Following its launch, NVS-02 was successfully placed in a Geosynchronous Transfer Orbit (GTO), but without the ability to activate its thrusters, it remains stuck in ...

The NVS-02 satellite has encountered a critical issue due to a faulty valve that supplies oxidizer to the Liquid Apogee Motor (LAM). Listen to Story The GSLV had deployed the satellite in the GTO ...

The Indian Space Research Organisation encountered a piece of bad luck with its NVS-02 satellite, a crucial component of India's indigenous navigation system, NavIC. Launched on January 29, 2025, ...

According to the latest update by Isro, the NVS-02 navigation satellite, which was launched on Wednesday (January 29), could not complete its orbit-raising operations after it failed to ignite a fire ...

Girish Linganna Updated : Feb 03, 2025, 08:21 AM IST The Indian Space Research Organisation (ISRO) announced on Sunday, February 2, that its NVS-02 navigation satellite, launched on January 29 aboard ...

ISRO faced a hurdle in its attempts to place the NVS-02 satellite in the desired orbit after the thrusters on board the spacecraft were not able to fire, the space agency said on Sunday. The NVS-02 ...

The NVS-02 satellite, which was crucial for India's own space-based navigation system, was launched on January 29. Follow Us Trending Photos New Delhi: ISRO's attempts to place the NVS-02 satellite in ...

The Indian Space Research Organisation (ISRO) has been unable to perform the intended orbit raising operations for the NVS-02 satellite due to a valve malfunction. The NVS-02, the second satellite ...

Proposed Dividend: CHF 3.50 per share, a 6% increase. Novartis AG (NYSE:NVS) reported a strong financial performance for 2024, with a 16% increase in Q4 sales and a 29% rise in core operating ...

Good morning and good afternoon, and welcome to the Novartis Q4 2024 Results Release Conference Call and Live Webcast. [Operator Instructions] A recording of the conference call, including the Q&A ...

With its Q4 2024 financials on Friday, Novartis (NYSE:NVS) (OTCPK:NVSEF) indicated a delayed timeline for initial data from a Phase 3 trial for a cardiac therapy it co-develops with Ionis ...